• Japanese Adult Moyamoya trial suggest EC-IC bypass may prevent re-bleeds

    Optimal management of many patients with adult-onset moyamoya disease who experience intracerebral hemorrhage (ICH) is unclear. The prospective Japanese Adult Moyamoya trial randomized patients with adult-onset moyamoya disease and history of ICH to bilateral extracranial–intracranial direct bypass or conservative care.  Eighty patients were enrolled (42 surgical; 38 nonsurgical).  Adverse events causing significant morbidity were observed in 6 surgical patients (14.3%) and 13 nonsurgical patients (34.2%). Rebleeding was observed in 5 surgical patients (11.9%) and 12 nonsurgical patients (31.6%). Although only marginal in statistical significance, the surgical group showed decreased adverse events and rebleeding episodes, suggesting a direct bypass benefit. Further studies are needed to confirm whether these findings apply to non-Japanese moyamoya patients, and to determine the potential benefits for overall functional outcome.


    National Center for Biotechnology Information

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site here. Privacy Policy